Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics. 1981

J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon

Platelet monoamine oxidase (MAO) activity was studied in three subpopulations of density-fractionated platelets in 15 unmedicated chronic paranoid schizophrenic patients and contrasted with normal controls. No significant difference in MAO activity was found in any of the three platelet fractions in schizophrenics compared to controls. Enzyme kinetic studies performed on the intermediate-density platelet fraction demonstrated no significant differences in Vmax or Michaelis' constant (Km) between schizophrenics and controls, but showed that the higher platelet MAO activity reported in females compared to male is due to a significantly greater Vmax rather than altered Km. It is suggested that conflicting results reported in the literature regarding platelet MAO in schizophrenia are not related to the platelet subpopulations studied but are largely due to the selected patient populations.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012563 Schizophrenia, Paranoid A chronic form of schizophrenia characterized primarily by the presence of persecutory or grandiose delusions, often associated with hallucination. Delusional Disorder,Paranoid Schizophrenia,Delusional Disorders,Disorder, Delusional,Disorders, Delusional,Paranoid Schizophrenias,Schizophrenias, Paranoid

Related Publications

J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
February 1988, Thrombosis and haemostasis,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
August 1986, Neuroscience letters,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
January 1986, Biological psychiatry,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
July 1975, Psychopharmacology bulletin,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
October 1978, Psychopharmacology,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
June 1981, Archives of general psychiatry,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
April 2014, Journal of neural transmission (Vienna, Austria : 1996),
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
January 1980, Schizophrenia bulletin,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
November 1981, Biochemical pharmacology,
J J Mann, and R D Kaplan, and A Georgotas, and E Friedman, and M Branchey, and S Gershon
November 1975, National Institute on Drug Abuse research monograph series,
Copied contents to your clipboard!